Source: Annual Congress 2013 –Basic research on lung cancer
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Frisch, A. Harst, K. Zimmermann, A. Pfeifer, P. Mayer, K. Racké (Bonn, Germany). Role of insulin and IGF-1 receptors in bronchial epithelial cancer cells. Eur Respir J 2013; 42: Suppl. 57, 3107

Member's Comments

No comment yet.

Related content which might interest you: Neurotrophin TrkB receptor mediates the epithelial to mesenchymal transition in lung adenocarcinoma cells Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Association of the endothelin-1 and endothelin A receptor genetic polymorphisms and non-small cell lung cancer in Taiwan Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Clinical significance of erythropoietin (Epo) and its receptor (EpoR) in non-small cell lung carcinoma Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Effect of 17-oxo-DHA alone and in combination with gemcitabine on lung cancer cell growth Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Association between leptin and risk of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Expression and clinical implications of the estrogen receptor β in lung adenocarcinoma Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Glucocorticoid reduces pemetrexed sensitivity by mediating senescence-associated secretory phenotype in Bcl-2 dependent manner in non-small-cell lung cancer Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Lung cancer patients harbouring epidermal growth factor receptor mutation Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Expression of interleukin-18 and interleukin-18 receptor mRNA in lung tissue samples from non small lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Distribution of CD4+Foxp3+,CD4+ and CD8+ T cells in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Frequency and type of EGFR mutations in patients with adenocarcinoma of the lung Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Dihydroartemisinin combined with cisplatinum induced apoptosis and related mechanism research in human lung adenocarcinoma H1299 cells Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 LATE-BREAKING ABSTRACT: Decreased sirtuin expression in squamous cell carcinoma compared to adenocarcinoma Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Novel two mechanisms for acquired EGFR-TKI resistance in lung cancer cells harboring EGFR activating mutation Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014